MS Drugs: Expensive, Often Lifelong, and Not Cost Effective

Manag Care. 2018 Oct;27(10):30-34.

Abstract

Multiple sclerosis is an on-again, off-again condition that vexes patients and their loved ones. The unpredictability makes is difficult to manage in all respects, especially with escalating prices wreaking havoc with the cost effectiveness of the medications used to contain the disease.

Keywords: Autoimmune Diseases of the Nervous System; Cost-Benefit Analysis; Multiple Sclerosis.

MeSH terms

  • Cost-Benefit Analysis*
  • Drug Costs* / statistics & numerical data
  • Humans
  • Managed Care Programs
  • Multiple Sclerosis / drug therapy*
  • United States